Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M238Revenue $M1.1Net Margin (%)-924.0Z-Score-31.2
Enterprise Value $M260EPS $-0.4Operating Margin %-785.1F-Score4
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-924.0Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio1.5Cash flow > EarningsY
Price/Sales49.65-y EBITDA Growth Rate %59.1Current Ratio1.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-129.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M151ROI % (ttm)-168.4Gross Margin Increase y-yN

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

NAVB is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GOLDBERG MICHAEL MDirector 2014-11-14Buy100,000$1.0843.52view
FORD BRENDAN ADirector 2014-11-10Buy10,000$1.0350.49view
Nordlicht Mark10% Owner 2014-09-02Sell60,000$1.3613.97view
Regan William J.SVP-Global Reg Affairs&Quality 2014-05-12Buy5,000$1.438.39view
PYKETT MARK JEROMECEO 2014-05-09Buy10,000$1.3415.67view
Cope Frederick OSVP 2014-03-10Sell15,000$1.96-20.92view
LARSON BRENT LEVP, CFO, Treas & Secy 2014-03-10Sell41,500$1.96-20.92view
PYKETT MARK JEROMECEO 2014-03-10Sell120,000$1.96-20.92view
FORD BRENDAN ADirector 2013-11-08Buy20,000$1.456.9view
LARSON BRENT LEVP, CFO, Treas & Secy 2013-11-08Buy5,000$1.3911.51view

Press Releases about NAVB :

    Quarterly/Annual Reports about NAVB:

    News about NAVB:

    Articles On GuruFocus.com
    Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 
    comment on NAVB Mar 15 2013 

    More From Other Websites
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 17 2014
    1:10 pm Navidea Biopharma's Macrophage Therapeutics presented data by independent collaborators that... Dec 15 2014
    Data Presented by Independent Academic Collaborators Demonstrate Ability of Novel Manocept™... Dec 15 2014
    Macrophage Therapeutics to Present Data Supporting Potential for Breakthrough with Manocept™ in... Dec 12 2014
    Macrophage Therapeutics to Present Data Supporting Potential for Breakthrough with Manocept™ in... Dec 12 2014
    Navidea Forms Macrophage Therapeutics Business Unit to Explore Therapeutic Applications of... Dec 10 2014
    Navidea Forms Macrophage Therapeutics Business Unit to Explore Therapeutic Applications of... Dec 10 2014
    Navidea Biopharmaceuticals to Present at the 2014 LD Micro Conference Nov 25 2014
    Navidea Biopharmaceuticals to Present at the 2014 LD Micro Conference Nov 25 2014
    European Commission Approves Navidea’s Sentinel Lymph Node Detection Agent Lymphoseek® Nov 20 2014
    European Commission Approves Navidea’s Sentinel Lymph Node Detection Agent Lymphoseek® Nov 20 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Financials Nov 18 2014
    Navidea Biopharmaceuticals (NAVB) Jumps: Stock Up 7.8% Nov 18 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Nov 13 2014
    10-Q for Navidea Biopharmaceuticals, Inc. Nov 12 2014
    Navidea Receives $1.1Million PDUFA Filing Fee Refund for Award of Orphan Drug Status; Platinum... Nov 11 2014
    Navidea Receives $1.1Million PDUFA Filing Fee Refund for Award of Orphan Drug Status; Platinum... Nov 11 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 10 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 06 2014
    Navidea Biopharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Nov 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK